The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 201–300 of 1,000
Chen, D., Lee, J. H., Gu, X., Wei, L., & Yu, S. P. (2015) · ASN NEURO · doi:10.1177/1759091415605114 · Cited by 117
“Because microglial activation following ischemic injury was known to release the pro- or anti-inflammatory cytokines (Lucas et al., 2006), we measured the levels of the inflammatory cytokines and chemokines in the penumbra region at 24 hr and 3 days after stroke.”
BackgroundHydrogen sulfide exposure induces jejunum injury via CYP450s/ROS pathway in broilers
Zheng, S., Jin, X., Chen, M., Shi, Q., Zhang, H., & Xu, S. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.09.002 · Cited by 115
Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases
Ghasemi, M., & Fatemi, A. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.002 · Cited by 115
Svetlov, S. I., Larner, S. F., Kirk, D., Atkinson, J., Hayes, R. L., & Wang, K. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0609 · Cited by 115
“The role of inflammation in various CNS injuries has been shown in numerous studies (see Lucas et al., 2006 for review).”
Leinhase, I., Rozanski, M., Harhausen, D., Thurman, J. M., Schmidt, O. I., Hossini, A. M., Taha, M. E., Rittirsch, D., Ward, P. A., Holers, V. M., et al. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-13 · Cited by 108
“These compensatory effects include the release of pro-inflammatory cytokines in the injured brain, such as tumor necrosis factor (TNF) and of interleukins (IL) -1β, -8, -12, -18, and other mediators of neuroinflammation [2,45,46].”
Huang, L., Guan, T., Qian, Y., Huang, M., Tang, X., Li, Y., & Sun, H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.175 · Cited by 104
Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens
Evseev, D., & Magor, K. E. (2019) · Veterinary Sciences · doi:10.3390/vetsci6010005 · Cited by 115
“Uncontrolled inflammation in other sensitive tissues, like in the CNS, can be equally dangerous [57].”
BackgroundNunes, P. T., Kipp, B. T., Reitz, N. L., & Savage, L. M. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.09.002 · Cited by 114
“Neuroimmune signaling initiates with the activation of glial cells, microglia and astrocytes , which lead to the production of neuroimmune factors such as cytokines, chemokines, as well as neurotoxic factors such as glutamate and free radical species, which can induce or exacerbate brain damage (Block et al., 2007; Lu…”
BackgroundWang, S., Sun‐Waterhouse, D., Waterhouse, G. I. N., Zheng, L. P., Su, G., & Zhao, M. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.04.056 · Cited by 114
Park, K. W., Lee, H. G., Jin, B. K., & Lee, Y. B. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.88 · Cited by 93
“It has been believed that inflammatory conditions created either in vivo or in vitro cause neurodegeneration through the release of inflammatory mediators and neurotoxic factors (Allan and Rothwell, 2001; Lucas et al., 2006).”
Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
Sharma, R., Leung, W. L., Zamani, A., O'Brien, T. J., Casillas-Espinosa, P. M., & Semple, B. D. (2019) · Brain Sciences · doi:10.3390/brainsci9110318 · Cited by 113
“Although it was historically believed that the brain was an immune-privileged site, due to the presence of the BBB which separates the brain from the peripheral immune system, it is now widely accepted that neuroinflammation is a key component of the brain’s defense mechanisms [28].”
BackgroundLabus, J., Häckel, S., Lucka, L., & Danker, K. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.03.002 · Cited by 113
Tong, W., Chen, X., Song, X., Chen, Y., Jia, R., Zou, Y., Li, L., Yin, L., He, C., Liang, X., et al. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8396 · Cited by 112
Kip, E., & Parr‐Brownlie, L. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1092537 · Cited by 113
“Drugs that target neuroinflammation, such as COX-2 inhibitors, are also now considered treatments for psychiatric diseases (Lucas et al., 2006).”
BackgroundMangiferin decreases inflammation and oxidative damage in rat brain after stress
Márquez, L., García-Bueno, B., Madrigal, J. L. M., & Leza, J. C. (2012) · European Journal of Nutrition · doi:10.1007/s00394-011-0252-x · Cited by 111
Wylie, G. R., & Flashman, L. A. (2017) · Concussion · doi:10.2217/cnc-2017-0003 · Cited by 112
“immune cells and activate glial cells (for a review see [67]).”
BackgroundMuramatsu, R., Takahashi, C., Miyake, S., Fujimura, H., Mochizuki, H., & Yamashita, T. (2012) · Nature Medicine · doi:10.1038/nm.2943 · Cited by 111
Barakat, R., Lin, P.-C., Park, C. J., Best-Popescu, C., Bakry, H. H., Abosalem, M. E., Abdelaleem, N. M., Flaws, J. A., & Ko, C. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy103 · Cited by 105
Therapeutic evaluation of etanercept in a model of traumatic brain injury
Chio, C., Lin, J., Chang, M., Wang, C., Kuo, J., Yang, C., & Chang, C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06969.x · Cited by 100
Kesinger, M. R., Kumar, R. G., Wagner, A. K., Puyana, J. C., Peitzman, A. P., Billiar, T. R., & Sperry, J. L. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000526 · Cited by 110
“It is now well established that TBI results in a considerable inflammatory response that includes both peripheral and central production of proinflammatory cytokines, chemokines, and cell adhesion molecules.(35,36) The inflammatory response is necessary to clear cellular debris in the central nervous system after inju…”
BackgroundTesco, G., & Lomoio, S. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101628 · Cited by 111
The role of macrophages in optic nerve regeneration
Cui, Q., Yin, Y., & Benowitz, L. I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.036 · Cited by 109
Han, B., Li, X., & Hao, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.002 · Cited by 108
“The detrimental effects on neurons in stroke patients are usually followed by the activation of microgliaderived inflammatory molecules and the infiltration of circulating inflammatory cells (Lucas et al., 2006; Jin et al., 2010).”
BackgroundInflammation in Focus: The Beginning and the End
Kiss, A. L. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2021.1610136 · Cited by 108
“Various forms of IL1, TNFα, IL-6, together with free radicals, ROS (causing damage of lipids, proteins and DNA) can significantly promote myelin sheath loss, injury of neurons, inducing neurodegeneration, serious neurodegenerative diseases like Alzheimer’s disease, lateral sclerosis, multiple sclerosis, Parkinson dise…”
BackgroundSelective Oestrogen Receptor Modulators Decrease the Inflammatory Response of Glial Cells
Arevalo, M. A., Diz‐Chaves, Y., Santos‐Galindo, M., Bellini, M. J., & Garcia‐Segura, L. M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02156.x · Cited by 98
Therapeutics targeting the inflammasome after central nervous system injury
de Rivero Vaccari, J. P., Dietrich, W. D., & Keane, R. W. (2016) · Translational Research · doi:10.1016/j.trsl.2015.05.003 · Cited by 98
Rana, A. K., & Singh, D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.006 · Cited by 98
“The literature available indicates that activated microglial in response to ischemia releases several pro-inflammatory cytokines such as TNF- a, IL-6, ILb and many other cytotoxic molecules including ROS, NO, and prostanoids that damage the brain (Lucas et al., 2006).”
Li, X., Huang, L., Liu, G., Fan, W., Li, B., Liu, R., Wang, Z., Fan, Q., Xiao, W., Li, Y., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112365 · Cited by 106
Chemokines as pain mediators and modulators
White, F. A., & Wilson, N. M. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32830eb69d · Cited by 106
Brain Cytokines and Chemokines: Roles in Ischemic Injury and Pain
Minami, M., Katayama, T., & Satoh, M. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj06005x · Cited by 98
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
“COX-1/2 is induced as part of the plaqueassociated inflammatory response in AD patients, and one of its major roles is to metabolize prostaglandins, which can be neurotoxic at supraphysiologic levels (Lucas et al., 2006).”
Jeena, K., Liju, V. B., Umadevi, N. P., & Kuttan, R. (2014) · Journal of Essential Oil Bearing Plants · doi:10.1080/0972060x.2013.831562 · Cited by 104
Perturbed cellular response to brain injury during aging
Popa‐Wagner, A., Buga, A.-M., & Kokaia, Z. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.10.008 · Cited by 104
“…of tissue damage is due mainly to inflammatory interactions involving cytokines, chemokines and leukocytes, as well as neurotoxic factors such as the C-terminal fragment of the b-amyloid precursor protein (bAPP) (Popa-Wagner et al., 1998; Badan et al., 2003; Badan et al., 2004; Lucas et al., 2006).”
Yanguas-Casás, N., Barreda-Manso, M. A., Nieto-Sampedro, M., & Romero-Ramírez, L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-50 · Cited by 103
“CNS glial cells can regulate this inflammatory response [3-5].”
Background“No-reflow” phenomenon in acute ischemic stroke
Zhang, Y., Jiang, M., Gao, Y., Zhao, W., Wu, C., Li, C., Ming, L., Wu, D., Wang, W., & Ji, X. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231208476 · Cited by 103
“For instance, ROS can intensify damage to ECs, exposing the ECM and promoting microglia activation, 119 This process mediates the adhesion and infiltration of leukocytes that obstruct microvessels.”
Background[18F]DPA-714: Direct Comparison with [11C]PK11195 in a Model of Cerebral Ischemia in Rats
Boutin, H., Prenant, C., Maroy, R., Galea, J., Greenhalgh, A. D., Smigova, A., Cawthorne, C., Julyan, P., Wilkinson, S. M., Banister, S. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056441 · Cited by 89
“of disease progression [1–6].”
Self-citationHippocampal dysfunctions in tumor-bearing mice
Yang, M., Kim, J., Kim, J., Kim, S., Kim, J.-C., Kang, M., Jung, U., Shin, T., Wang, H., & Moon, C. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.10.022 · Cited by 102
“Thus, inflammatory mediators originating in both the periphery and the brain can stimulate production of cytokines in the CNS; these materials, in turn, influence pathways involved in the regulation of mood and cognition (Das, 2006; Dinel et al., 2011; Lucas et al., 2006).”
BackgroundTherapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus
Jiang, J., Yang, M.-S., Quan, Y., Gueorguieva, P., Ganesh, T., & Dingledine, R. J. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.032 · Cited by 102
“ered immune-privileged, inflammation within the brain, also known as neuroinflammation, is now emerging as a salient feature of many chronic neurological conditions that might contribute to the pathogenesis of these diseases (Aronica and Crino, 2011; Lucas et al., 2006; Varvel et al., 2015; Wee Yong, 2010).”
InfluentialPiperine attenuates lipopolysaccharide (LPS)-induced inflammatory responses in BV2 microglia
Wang-sheng, C., Jie, A., Jian-jun, L., Hong, L., Zeng-bao, X., & Li, C. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.001 · Cited by 100
McMahon, D., Poon, C., & Hynynen, K. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1567490 · Cited by 94
Roboon, J., Hattori, T., Ishii, H., Takarada‐Iemata, M., Nguyen, D. T., Heer, C. D., O’Meally, D., Brenner, C., Yamamoto, Y., Okamoto, H., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15367 · Cited by 101
“However, insufficient control of neuroinflammation leads to the progression of many neurological conditions such as multiple sclerosis, traumatic brain injury, and Alzheimer's disease (Akiyama et al., 2000; Frischer et al., 2009; Lucas et al., 2006).”
BackgroundKiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 89
“As the cells serve as scavengers (El Khoury et al.,1998; Lucas et al., 2006; Paresce et al., 1996), we investigated whether CCL2 deficiency could affect phagocytic functions.”
BackgroundBrain-Region-Specific Astroglial Responses In Vitro After LPS Exposure
Kipp, M., Norkutė, A., Johann, S., Lorenz, L., Braun, A., Hieble, A., Gingele, S., Pott, F., Richter, J., & Beyer, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9057-7 · Cited by 100
“In fact, molecules of the innate and adaptive immune system, including astrocyte-derived immune modulators, are implicated in the pathogenesis of several neurological disorders, i.e., PD, MS, and stroke (Mennicken et al. 1999; Lucas et al. 2006).”
BackgroundPatel, R. K., Prasad, N., Kuwar, R., Haldar, D., & Muneer, P. M. A. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.012 · Cited by 100
Halim, A., Qu, K.-Y., Zhang, X.-F., & Huang, N. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00490 · Cited by 99
Vitamin B12 in neurology and ageing; Clinical and genetic aspects
McCaddon, A. (2012) · Biochimie · doi:10.1016/j.biochi.2012.11.017 · Cited by 99
Microfluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Peña-Philippides, J. C., Yang, Y., Bragina, O. A., Hagberg, S., Nemoto, E. M., & Roitbak, T. (2014) · Translational Stroke Research · doi:10.1007/s12975-014-0334-1 · Cited by 98
“Stroke is followed by acute and prolonged inflammatory response including the activation of glial cells, production of inflammatory cytokines, and infiltration of monocytes into the brain [4].”
Frontal Cortex Neuropathology in Dementia Pugilistica
Saing, T., Dick, M., Nelson, P. T., Kim, R. C., Cribbs, D. H., & Head, E. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.1957 · Cited by 90
“Microglial cell activation may result in the release of proinflammatory cytokines and chemokines and exacerbate neuronal dysfunction (Lucas et al., 2006; Nguyen et al., 2002).”
García-Bueno, B., Madrigal, J. L. M., Pérez-Nievas, B. G., & Leza, J. C. (2008) · Endocrinology · doi:10.1210/en.2007-0482 · Cited by 97
“antiinflammatory prostaglandins) (6), and the activation of”
Ikram, M., Saeed, K., Khan, A., Muhammad, T., Khan, M., Jo, M., Rehman, S., & Kim, M. (2019) · Nutrients · doi:10.3390/nu11051082 · Cited by 97
“The neurodegenerative effects are associated with neuroinflammation, apoptotic cell death [6], and synaptic dysfunction [7,8].”
RetractedImpact of heat stress on rumen functions
Yadav, B., Singh, G., Verma, A. K., Dutta, N., & Sejian, V. (2013) · Veterinary World · doi:10.14202/vetworld.2013.992-996 · Cited by 97
How air pollution threatens brain health
Peeples, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008940117 · Cited by 97
Mulabagal, V., Wang, H., Ngouajio, M., & Nair, M. G. (2009) · European Food Research and Technology · doi:10.1007/s00217-009-1144-7 · Cited by 96
Interleukin-18, From Neuroinflammation to Alzheimers Disease
Bossu, P., Ciaramella, A., Salani, F., Vanni, D., Palladino, I., Caltagirone, C., & Scapigliati, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210794519147 · Cited by 89
“In fact, whilst acute neuroinflammatory responses are generally short-lived reactions with protective effects, chronic inflammatory processes in CNS are believed to lead to neuronal damage [21, 22].”
BackgroundSystems pharmacology and genome medicine: a future perspective
Wist, A. D., Berger, S., & Iyengar, R. (2009) · Genome Medicine · doi:10.1186/gm11 · Cited by 95
“There is accumulating evidence to support this hypothesis [26,27].”
BackgroundEffect of Rosuvastatin on Amnesia and Disorientation after Traumatic Brain Injury (NCT00329758)
Tapia-Perez, J. H., Sanchez-Aguilar, M., Torres-Corzo, J. G., Gordillo-Moscoso, A., Martinez-Perez, P., Madeville, P., de la Cruz-Mendoza, E., & Chalita-Williams, J. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0554 · Cited by 86
Complement Factor H: Spatial and Temporal Expression and Localization in the Eye
Mandal, N. A., & Ayyagari, R. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1655 · Cited by 85
“Proteins of the complement system are associated with Alzheimer disease (AD) lesions; one risk factor for AD is acute brain injury leading to long-term inflammation with increased expression of major histocompatibility complex (MHC) class II, IL-1, and TNFproteins.(42) The neurons are particularly susceptible to compl…”
BackgroundBhowmick, S., D’Mello, V., Caruso, D., & Muneer, P. M. A. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01851-4 · Cited by 94
Apelin/APJ system in inflammation
Wang, X., Zhang, L., Li, P., Zheng, Y., Yang, Y., & Ji, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108822 · Cited by 93
Biochemical aspects of inflammation
Kulinsky, V. I. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907060028 · Cited by 93
Inflammatory response in heroin addicts undergoing methadone maintenance treatment
Chan, Y.-Y., Yang, S., Lin, J., Chang, J.-L., Lin, J., & Lo, W. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.053 · Cited by 93
“IL-6 levels were elevated in patients with various CNS disorders, such as epilepsy, depression, Alzheimer's disease, Parkinson's disease and schizophrenia (Lucas et al., 2006) and studies have proposed that IL-6 is a neurodegenerative factor that is involved in the pathomechanisms of Alzheimer's disease (BlumDegen et…”
BackgroundInfluentialComplement and blood–brain barrier integrity
Jacob, A., & Alexander, J. J. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.039 · Cited by 93
Annexin A1 in the brain – undiscovered roles?
Solito, E., McArthur, S., Christian, H., Gavins, F. N. E., Buckingham, J. C., & Gillies, G. E. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.003 · Cited by 92
Li, C., Li, X., Liu, S.-F., Qu, W., Wang, W., & Tian, D. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.03.001 · Cited by 92
“Astrocyte activation is always accompanied by production of inflammation mediators, such as TNF-α, NO and iNOS, which is involved in secondary neuronal cell death after CNS injuries (Iadecola et al., 1995; Zhang et al., 2009).”
BackgroundInfluentialLópez-Rodríguez, A. B., Siopi, E., Finn, D. P., Marchand‐Leroux, C., García‐Segura, L. M., Jafarian-Tehrani, M., & Viveros, M. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht202 · Cited by 92
Kong, L., Wang, Z. Y., Han, N., Zhuang, X. M., Wang, Z. Z., Li, H., & Chen, N. H. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-112 · Cited by 92
“Most experimental and clinical studies support the importance of neutrophil infiltration in ischemic stroke [31,41].”
BackgroundmiR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α
Xing, F., Sharma, S., Liu, Y., Mo, Y.-Y., Wu, K., Zhang, Y., Pochampally, R. R., Martinez, L. A., Lo, H., & Watabe, K. (2015) · Oncogene · doi:10.1038/onc.2014.412 · Cited by 92
Kline, A. E., Leary, J. B., Radabaugh, H. L., B, J. P. C. A., & Bondi, C. O. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.002 · Cited by 93
Towards Retinoid Therapy for Alzheimers Disease
Shudo, K., Fukasawa, H., Nakagomi, M., & Yamagata, N. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486581 · Cited by 91
Effect of rosuvastatin on cytokines after traumatic head injury: Clinical article
Sánchez-Aguilar, M., Tapia-Pérez, J. H., Sánchez-Rodríguez, J. J., Viñas-Ríos, J. M., Martínez-Pérez, P., Mendoza, E. D. L. C., Sánchez-Reyna, M., Torres-Corzo, J. G., & Gordillo‐Moscoso, A. (2013) · Journal of neurosurgery · doi:10.3171/2012.12.jns121084 · Cited by 91
Salvador, E., Burek, M., & Förster, C. Y. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00323 · Cited by 91
Zhang, Y., Liu, J., Yang, B., Zheng, Y., Yao, M., Sun, M., Xu, L., Lin, C.-R., Chang, D., & Tian, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00518 · Cited by 91
“Inflammation may ultimately lead to neuronal cell death by inducing the entry of leukocytes (Lucas et al., 2006), the release of inflammatory cytokines (Lambertsen et al., 2012), and apoptosis (Pettigrew et al., 2008).”
BackgroundLateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats
Das, M., Leonardo, C. C., Rangooni, S., Pennypacker, K. R., Mohapatra, S., & Mohapatra, S. S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-148 · Cited by 90
“Because splenic CCL20 expression was increased in the acute phase of TBI injury (24 h postinsult) and the splenic inflammatory response is known to exacerbate neural injury [10,17,18] experiments were performed to determine whether CCL20 expression is associated with neural injury.”
BackgroundGao, W., Zhao, Z., Yu, G., Zhou, Z., Zhou, Y., Hu, T., Jiang, R., & Zhang, J. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.035 · Cited by 90
Kipp, M., Karakaya, S., Pawlak, J., de Araújo, G. W., Arnold, S., & Beyer, C. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.07.001 · Cited by 90
Duarte-Delgado, N. P., Vásquez, G. M., & Ortíz-Reyes, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.12.004 · Cited by 90
Gene expression profile analysis of epilepsy-associated gangliogliomas
Aronica, E., Boer, K., Becker, A. J., Redeker, S., Spliet, W. G. M., van Rijen, P. C., Wittink, F. R. A., Breit, T. M., Wadman, W. J., Lopes, F. H. D. S., et al. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.036 · Cited by 89
BAKER, A. J., Rhind, S. G., Morrison, L. J., Black, S. E., Crnko, N. T., Shek, P. N., & Rizoli, S. B. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0868 · Cited by 89
Li, M., Li, F., Luo, C., Shan, Y., Zhang, L., Qian, Z., Zhu, G., Lin, J., & Feng, H. (2011) · Journal of Trauma: Injury, Infection & Critical Care · doi:10.1097/ta.0b013e3181f30fc9 · Cited by 83
Martínez‐Gras, I., Perez‐Nievas, B. G., García‐Bueno, B., Madrigal, J. L. M., Andres, E. M., Rodríguez–Jiménez, R., Hoenicka, J., Palomo, T., Rubio, G., & Leza, J. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.018 · Cited by 90
“Over the past two decades, inflammation, caused by both external and endogenous factors, has been implicated as a main pathophysiological feature of chronic mental illnesses, including schizophrenia (Lucas et al., 2006).”
BackgroundPropofol Inhibits NLRP3 Inflammasome and Attenuates Blast-Induced Traumatic Brain Injury in Rats
Ma, J., Xiao, W., Wang, J., Wu, J., Ren, J., Hou, J., Gu, J., Fan, K., & Yu, B. (2016) · Inflammation · doi:10.1007/s10753-016-0446-8 · Cited by 89
“Inflammation is a typical response with recruitment of inflammatory cells inducing cascades of secondary damages following various CNS injuries, which may be a significant determinant of the eventual outcomes [24, 25].”
Petcu, E. B., Sfredel, V., Platt, D., Herndon, J. G., Kessler, C., & Popa‐Wagner, A. (2007) · Gerontology · doi:10.1159/000112845 · Cited by 88
“Similar findings have been reported recently for poststroke recovery of mice prone to accelerated senescence [ , , , , , ,”
ResultChen, C.-C., Hung, T., Wang, Y., Lin, C., Wang, P., Lee, C.-Y., & Chen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030294 · Cited by 88
“secondary brain injury following TBI [27,28].”
Hyperglycemia in stroke and possible treatments
Li, W. A., Moore-Langston, S., Chakraborty, T., Rafols, J. A., Conti, A. C., & Ding, Y. (2013) · Neurological Research · doi:10.1179/1743132813y.0000000209 · Cited by 82
Re-thinking the Etiological Framework of Neurodegeneration
Castillo, X., Castro-Obregón, S., Gutiérrez-Becker, B., Gutiérrez-Ospina, G., Karalis, N., Khalil, A. A., Lopez-Noguerola, J. S., Rodríguez, L. L., Martínez-Martínez, E., Perez-Cruz, C., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00728 · Cited by 79
“Chronic low-grade inflammation contributes to the increased risk of cerebrovascular disease (Lucas et al., 2006) and was shown to be a feature of the aging (Buga et al.”
BackgroundGresa‐Arribas, N., Serratosa, J., Saura, J., & Solà, C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06952.x · Cited by 87
Integration of cytokine biology and lipid metabolism in stroke
Adibhatla, R. M. (2008) · Frontiers in Bioscience · doi:10.2741/2759 · Cited by 77
“Thus after a CNS insult, the initial upregulation of cytokines will lead to infiltration of other inflammatory mediators to the site of injury and secondary cytokine signaling is subsequently initiated (78).”
Stress and social isolation increase vulnerability to stroke
Stuller, K. A., Jarrett, B. L., & DeVries, A. C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.016 · Cited by 87
Nakamura, T., Yamamoto, E., Kataoka, K., Yamashita, T., Tokutomi, Y., Dong, Y.-F., Matsuba, S., Ogawa, H., & Kim-Mitsuyama, S. (2007) · Stroke · doi:10.1161/strokeaha.107.486522 · Cited by 81
Stein, D. M., Lindell, A. L., Murdock, K. R., Kufera, J. A., Menaker, J. A., Keledjian, K. M., Bochicchio, G. V., Aarabi, B., & Scalea, T. M. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e318216930d · Cited by 88
Ge, X., Huang, S., Gao, H., Han, Z., Chen, F., Zhang, S., Wang, Z., Kang, C., Jiang, R., Yue, S., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.015 · Cited by 86
Wei, H. H., Lu, X.-C. M., Shear, D. A., Waghray, A., Yao, C., Tortella, F. C., & Dave, J. R. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-19 · Cited by 81
“Page 1 of 10 (page number not for citation purposes) Background In the United States, traumatic brain injury (TBI) is the primary cause of death and disability in persons under 45 years old, occurring more frequently than breast cancer, HIV-AIDS, multiple sclerosis, and spinal cord injury combined [1,2].”
InfluentialLiu, W., Wang, X., Yang, S., Huang, J., Xue, X., Zheng, Y., Shang, G., Tao, J., & Chen, L. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.01.045 · Cited by 85
Weng, L., Zhang, H., Li, X., Zhan, H., Chen, F., Han, L., Xu, Y., & Cao, X. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.12.018 · Cited by 85
Stress-Induced Cytokines and Neuronal Dysfunction in Alzheimer's Disease
Ricci, S., Fuso, A., Ippoliti, F., & Businaro, R. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110821 · Cited by 77
“In addition, neurons and glial cells are able to produce proinflammatory cytokines that bind to receptors constitutively expressed through the CNS [16].”
Lu, K., Cho, C.-L., Liang, C., Chen, S., Liliang, P., Wang, S.-Y., & Chen, H. (2007) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.11.038 · Cited by 84
Metallothionein‐I+II in neuroprotection
Pedersen, M. Ø., Jensen, R., Pedersen, D. S., Skjolding, A. D., Hempel, C., Maretty, L., & Penkowa, M. (2009) · BioFactors · doi:10.1002/biof.44 · Cited by 84
Kipp, M., Karakaya, S., Johann, S., Kampmann, E., Mey, J., & Beyer, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01588.x · Cited by 83
Coenzyme Q10: Novel Formulations and Medical Trends
Pastor‐Maldonado, C. J., Suarez-Rivero, J. M., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Munuera-Cabeza, M., Suárez-Carrillo, A., Talaverón-Rey, M., & Sánchez-Alcázar, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228432 · Cited by 84
“One of them is epilepsy, whose pathophysiology is characterized by both a severe mitochondrial dysfunction and neuroinflammation [77].”
Background
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.